Yoshifumi Shirakami¹, Victor Romanov¹, Tadashi Watabe¹, Kazuko Kaneda³, Yuway Liu¹, Atsushi Shinohara⁴, Eku Shimosegawa², Jun Hatazawa¹ (1.Department of Nuclear Medicine and Tracer Kinetics, Osaka University Graduate School of Medicine, Suita, Japan, 2.Department of Molecular Imaging in Medicine, Osaka University Graduate School of medicine, Suita Osaka, Japan, 3.Core for Medicine and Science Collaborative Research and Education, Project Research Center for Fundamental Sciences, Graduate School of Science, Osaka University, Toyonaka Osaka, Japan, 4.Department of Chemistry, Graduate School of Science, Osaka University, Toyonaka Osaka Japan)

Tetsuya Sakashita¹, Yasuhiro Ohshima¹, Nobuaki Kono², Yuichiro Yokota¹, Shigeki Watanabe¹, Ichiro Sasaki¹, Noriko S. Ishioka¹, Kazuharu Arakawa² (1.Department of Radiation-Applied Biology Research, National Institutes for Quantum and Radiological Science and Technology, Takasaki, Japan, 2.Institute for Advanced Biosciences, Keio University, Tsuruoka, Japan)

Huizi K. Li^1,2, Aya Sugyo³, Atsushi B. Tsuji³, Katsuyuki Minegishi⁴, Kotaro Nagatsu⁴, Yosuke Harada⁵, Satoshi Nagayama⁶, Toyomasa Katagiri⁷, Yusuke Nakamura⁸, Tastuya Higashi³, Sumitaka Hasegawa¹ (1.Radiation and Cancer Biology Team, NIRS, QST, 2.JSPS Research Fellow, 3.Dept. Molecular Imaging and Theranostics, NIRS, QST, 4.Targetry and Target Chemistry Team, NIRS, QST, 5.OncoTherapy Science, Inc., 6.Dept. Gastroenterological Surgery Cancer Institute Hospital, JFCR, 7.Div. Genome Medicine, Institute for Genome Research, Tokushima Univ., 8.Dept. Medicine, Univ. of Chicago)

Masayuki Hanyu¹, Lin Xie¹, Masayuki Fujinaga¹, Yiding Zhang¹, Akiko Hatori¹, Katsuyuki Minegishi¹, Keiko Li², Yukie Morokoshi², Sumitaka Hasegawa², Kotaro Nagatsu¹, Ming-Rong Zhang¹ (1.Department of Radiopharmaceuticals Development, National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology, Chiba, Japan, 2.Radiation and Cancer Biology Team, National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology, Chiba, Japan)

Shigeki Watanabe¹, Azim Mohammad Anwar-Ul², Ichiro Nishinaka¹, Ichiro Sasaki^1,3, Yasuhiro Ohshima¹, Keiichi Yamada³, Noriko Ishioka S.¹ (1.Department of Radiation-Applied Biology Research, National Institutes for Quantum and Radiological Science and Technology (QST), Takasaki, Japan, 2.National Institute of Nuclear Medicine & Allied Sciences (NINMAS), Bangladesh Atomic Energy Commission (BAEC), 3.Gunma University Graduate School of Science and Technology)

Lin Xie¹, Masayuki Hanyu¹, Masayuki Fujinaga¹, Yiding Zhang¹, Akiko Hatori¹, Katsuyuki Minegishi¹, Huizi Keiko Li^2,3, Yukie Morokoshi², Sumitaka Hasegawa², Kotaro Nagatsu¹, Ming-Rong Zhang¹ (1.Department of Radiopharmaceuticals Development, National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology, Chiba, Japan., 2.Department of Charged Particle Therapy Research, National Institute of Radiological Sciences, National Instituts for Quantum and Radiological Science and Technology, 3.Japan Society for the Promotion of Science)

Kazuhiro Ooe¹, Tadashi Watabe¹, Yoshifumi Shirakami¹, Soichiro Ichimura², Takumi Ikeda², Zi Zhang², Kojiro Nagata³, Atsushi Toyoshima^2,4, Takashi Yoshimura³, Atsushi Shinohara², Jun Hatazawa¹ (1.Graduate School of Medicine, Osaka University, Osaka, Japan, 2.Graduate School of Science, Osaka University, Osaka, Japan, 3.Radioisotope Research Center, Osaka University, Osaka, Japan, 4.Japan Atomic Energy Agency, Tokai, Japan)